Why the “Max Pain” Narrative is Failing to Predict Bitcoin’s Price Action
Published: June 25, 2026 | Updated: June 25, 2026
Key Takeaways
- Bitcoin has retreated from the $67,000 range to below $60,000, directly challenging the “max pain” hypothesis ahead of a $10 billion quarterly options settlement.
- With the current max pain threshold sitting at $72,000, the significant gap between spot prices and theoretical targets highlights the theory’s diminishing relevance in current market conditions.
- While the “pinning” effect has largely failed to materialize, the upcoming Deribit expiry remains a critical liquidity event that could trigger significant short-term volatility.
The Disconnect Between Theory and Market Reality
As the crypto market approaches a massive $10 billion quarterly options settlement on Deribit, the long-standing “max pain” theory is facing intense scrutiny. Bitcoin’s recent slide-dropping from $67,000 to under $60,000-stands in stark contrast to the expectations set by proponents of this model, who anticipated the price would gravitate toward the $72,000 mark.
The “max pain” concept posits that the market price will naturally gravitate toward a specific level where the majority of options contracts expire worthless, thereby inflicting the greatest financial loss on option buyers while benefiting the writers (sellers) of those contracts. Historically, this theory gained traction during the 2020-2021 bull cycle, where Bitcoin often appeared to “pin” itself to these calculated levels. However, recent market behavior suggests that this phenomenon may have been more coincidental than mechanical.
Expert Skepticism and the “Pinning” Myth
The failure of Bitcoin to rally toward the $72,000 target ahead of Friday’s 8:00 ET settlement has reinforced the views of seasoned market analysts. Critics have long argued that the max pain theory is an oversimplification of complex derivatives markets.
Jasper De Maere, an OTC trader at the prominent market maker Wintermute, noted that the mechanical “pinning” effect-where market makers supposedly manipulate spot prices to align with max pain-has been largely absent in recent cycles. “Despite it being a compelling narrative, recent option expiries haven’t really mechanically pinned down prices in the way people expect them to do,” De Maere explained. This sentiment echoes the long-standing skepticism of industry
